Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly

Sleep Medicine

Volumn 10, Issue 8, 2009, Pages 882-886

  Roche, Frédéric ^a   Sforza, Emilia ^b   Pichot, Vincent ^a   Maudoux, Delphine ^a   Garcin, Arnaultd ^a   Celle, Sébastien ^a   Picard Kossovsky, Michel ^c   Gaspoz, Jean Michel ^c   Barthélémy, Jean Claude ^a  

^a Laboratoire de Physiologie Clinique et de l'Exercice   (France)

^b Hôpitaux Universitaires de Reims   (France)

^c Faculty of Medicine   (Switzerland)

Author keywords

Cardiovasculat risk factors; Dyslipidaemia; Elderly; Epidemiology; HDL cholesterol; Obstructive sleep apnoea hypopnea; Sleep related breathing disorders

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYHEMOGLOBIN;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; IMMUNOASSAY; LINEAR REGRESSION ANALYSIS; MALE; MULTICHANNEL RECORDER; MULTIPLE REGRESSION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP APNEA SYNDROME; UNIVARIATE ANALYSIS; WAIST HIP RATIO;

AGED; AGING; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; LINEAR MODELS; MALE; PREVALENCE; RISK FACTORS; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE;

EID: 68949194138     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.07.017     Document Type: Article

References (40)

1. Gordon D.J., and Rifkind B.M. High-density lipoprotein - the clinical implications of recent studies. N Engl J Med 321 (1989) 1311-1316
2. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
3. Newman A.B., Nieto F.J., Guidry U., Lind B.K., Redline S., Shahar E., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154 (2001) 50-59
4. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
5. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., and Redline S. Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study. Sleep Heart health Study. JAMA 283 (2000) 1829-1836
6. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
7. Martínez-García M.A., Gómez-Aldaraví R., Soler-Cataluña J.J., Martínez T.G., Bernácer-Alpera B., and Román-Sánchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 29 (2007) 951-957
8. Börgel J., Sanner B.M., Bittlinsky A., Keskin F., Bartels N.K., Buechner N., et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 27 (2006) 121-127
9. Steiropoulos P., Tsara V., Nena E., Fitili C., Kataropoulou M., Froudarakis M., et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132 (2007) 843-851
10. Lavie P., Herer P., Peled R., Berger I., Yoffe N., Zomer J., et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 18 (1995) 149-157
11. Haas D.C., Foster G.L., Nieto F.J., Redline S., Resnick H.E., Robbins J.A., et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 11 (2005) 614-621
12. Barthélémy J.C., Pichot V., Dauphinot V., Celle S., Laurent B., Garcin A., et al. Autonomic nervous system activity and decline as prognostic indicators of cardiovascular and cerebrovascular events. The PROOF Study. Neuroepidemiology 29 (2007) 18-28
13. Sériès F., and Marc I. Nasal pressure recording in the diagnosis of sleep apnoea hypopnoea syndrome. Thorax 54 (1999) 506-510
14. Ancoli-Israel S., Kripke D.F., Mason W., and Messin S. Comparisons of home sleep recordings and polysomnograms in older adults with sleep disorders. Sleep 4 (1981) 283-291
15. Flemons W.W., Buysse D., Redline S., Pack A., Strohl K., Wheatley J., et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689
16. Argod J., Pépin J.L., Smith R.P., and Levy P. Comparison of esophageal pressure with pulse transit time as a measure of respiratory effort for scoring obstructive nonapneic respiratory events. Am J Respir Crit Care Med 162 (2000) 87-93
17. Pépin J.L., Delavie N., Pin I., Deschaux C., Argod J., Bost M., et al. Pulse transit time improves detection of sleep respiratory events and microarousals in children. Chest 127 (2005) 722-730
18. Mant A., Saunders N.A., and Eyland E.A. Sleep habits and sleep related respiratory disturbance in an older population. In: Horne J., et al. (Ed). Sleep'88 (1989), Gustav Fischer Verlag, Stuttgart 260-261
19. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
20. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Baker G., et al., On behalf of the SCORE project group. Cardiovascular disease prevention - risk assessment and management. Eur Heart J 24 (2003) 987-1003
21. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Rein J., Vela-Bueno A., et al. Prevalence of sleep-disordered breathing in women. Effects of gender. Am J Respir Crit Care Med 163 (2001) 608-613
22. Tan K.C., Chow W.S., Lam J.C., Lam B., Wong W.K., Tam S., et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184 (2006) 377-382
23. Buechner J., Zidek W., Esser M., Haske M., and Sanner B.M. Obstructive sleep apnea syndrome. Effects of therapy on dyslipidemia. Somnologie 5 (2001) 97-103
24. Waters K.A., Sitha S., O'Brien L.M., Bibby S., de Torres C., Vella S., et al. Follow-up on metabolic markers in children treated for obstructive sleep apnea. Am J Respir Crit Care Med 174 (2006) 455-460
25. Makino S., Handa H., Suzukawa K., Fujiwara M., Nakamura M., Muraoka S., et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 64 (2006) 12-19
26. Li J., Thorne L.N., Punjabi N.M., Sun C.K., Schwartz A.R., Smith P.L., et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97 (2005) 698-706
27. Li J., Savransky V., Nanayakkara A., Smith P.L., O'Donnell C.P., and Polotsky V.Y. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102 (2007) 557-563
28. Savransky V., Nanayakkara A., Li J., Bevans S., Smith P.L., Rodriguez A., et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175 (2007) 1290-1997
29. Lattimore J.D., Wilcox I., Nakhla S., Langenfeld M., Jessup W., and Celermajer D.S. Repetitive hypoxia increases lipid loading in human macrophages: a potentially atherogenic effect. Atherosclerosis 179 (2005) 255-259
30. Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., and Wilding J.P. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
31. Peled N., Kassirer M., Shitrit D., Kogan Y., Shlomi D., Berliner A.S., et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Resp Med 101 (2007) 1696-1701
32. Pavlova M.K., Duffy J.F., and Shea S.A. Polysomnographic respiratory abnormalities in asymptomatic individuals. Sleep 43 (2008) 241-248
33. Wolk R., and Somers V.K. Sleep and metabolic syndrome. Exp Physiol 92 (2007) 67-78
34. Marotta T., Ferrara L.A., DiMarino L., Mancini M., Annuzzi G., Russo O., et al. Factors affecting lipoprotein lipase in hypertensive patients. Metabolism 44 (1995) 712-718
35. Ferrara L.A., Marotta T., Rubba P., De Simone B., Leccia G., and Soro S. Effects of alpha-adrenergic and beta-adrenergic blockade on lipid metabolism. Am J Med 80 (1986) 104-108
36. Marrone O., Riccobona L., and Salvaggio A. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103 (1993) 722-727
37. Roche F., Court-Fortune I., Pichot V., Duverney D., Costes F., Emonot A., et al. Reduced cardiac sympathetic autonomic tone after long-term continuous positive airway pressure in obstructive sleep apnoea syndrome. Clin Physiol 19 (1999) 127-134
38. Narkiewicz K., Kato M., Philips B.G., Pesek C.A., Davidson D.E., and Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 (1999) 2332-2335
39. Liyori N., Alonso L.C., Li J., Sanders M.K., Garcia-Ocana A., O'Doherty R.M., et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175 (2007) 851-857
40. Leon A., and Sanchez O. Meta-analysis of the effects of aerobic exercise training on blood lipids. Circulation 104 (2001) 414-415